Document is current

Any future updates will be listed below

Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma

Crossref DOI link: https://doi.org/10.1136/jitc-2020-000807

Published Online: 2020-10-28

Published Print: 2020-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark